Merck (MRK)
$93.01
0.76 (0.81%)
MRK Stock Quote Delayed 30 Minutes
5 (New) Buys, and 5 ‘Deletions’ to the 2014 Stock Buy List
Last week I gave you my 2014 Stock Buy List; this week find out why I've chosen my 5 new "buys", and the 5 "deletions" for the list...
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$90.58
Market Cap
233.03B
PE Ratio
13.81
EPS
6.7363
Volume (Avg. Vol.)
14.13M
Day's Range
$90.71 - $92.35
52-Week Range
$81.04 - $132.70
Dividend & Yield
$3.12 (3.35%)
MRK Stock Predictions, Articles, and Merck News
17 Stocks With Ex-Dividend Dates to Put on Your Radar
It's a great time for dividends, and this list of 17 companies coming up on ex-dividend and dividend payout dates is a great way to find year end income
Top 10 Dow Dividend Stocks for November
These top 10 Dow dividend stocks might not have the screamingly highest yields of any stock in the market, but they're still good payouts, and they're reliable.
3 Turkeys to Sell Before Thanksgiving
It's getting close to Thanksgiving, and investors will enjoy the holiday even more after they sell these three stocks
New Guidelines: Doctors to Push Use of Cholesterol Drugs
New heart disease prevention guidelines will have doctors recommending cholesterol drugs to double the Americans than what the current guidelines do.
5 Overpriced Stocks to Ditch Now
These stocks are either momentum darlings or supposed bastions of safety, but their valuations aren't justified.
3 New Buys for November – ADS CLB TM
The government is open again, the Fed will continue easing, and a strong period for the markets is ahead. Here are our 3 new buys to help you profit
New Drug Could Cut ‘Bad’ Cholesterol Nearly in Half
Late stage trials of Alirocumab, an anti-cholesterol drug from Regeneron and Sanofi, showed promising results.
Top 11 Dow Dividend Stocks for September
Looking for big yield and security? Look no further than this list of the Dow Jones Industrial Average's top 11 dividend stocks.
4 Healthcare Investments to Make Before October
With open enrollment in state health insurance exchanges set to kick off on Oct. 1, it’s a good time to revisit the ways investors can play the opportunity.
5 Dividend Darlings to Dump Now
All dividend stocks are not created equal, and some companies with nice yields could still pose a big risk to your portfolio.
3 Pharma Stocks Just Running in Place
Gobs of free cash flow doesn't mean a company is worth buying. Some companies, especially pharmaceuticals, just use cash to run in place.
Should I Buy Zoetis? 3 Pros, 3 Cons
Animal medicines stock Zoetis has basically been treading water since its IPO. Is it a potential boomer in the making, or should you expect more flat going forward?
3 Healthcare Stocks With Healthy Dividends
Protect yourself from the headwinds facing healthcare stocks by snatching up names that offer -- and are likely to keep offering -- big-time dividends.
Pfizer & Merck: Dividend Winners or Duds?
Pfizer and Merck got addicted to Lipitor and Singulair, and now slumping sales of the former blockbusters have both companies scrambling for growth.
3 Funds to Play the Healthcare Megatrend
Healthcare has been hot in 2013, but more importantly, it's set up to be a huge mover going forward thanks to several big trends. Here's how to get your piece.
5 Megatrend Plays Offering Big Payouts
Megatrend investments usually require years if not decades to play out, but these five particular stocks offer investors some sizable income for waiting.
The Top 10 Dow Dividend Stocks for June
With so much uncertainty out there, investors could do a lot worse than buying into these venerable blue chips -- especially the reigning king of big payouts.
